Most people with a psychiatric disorder are going to be treated by a primary care doctor who may have little time or specialized training.

The Centers for Disease Control and Prevention should work to better educate prescribers, insurers and the public about what ADHD is and the best practices for treating it.

The regulation of ADHD medication also should be transferred from the DEA, which focuses on control, to the Food and Drug Administration, which focuses on health.

Instead of punishing patients who legitimately need the drugs, the DEA should focus more on the bad actors - those pushing pills for profit.

“You’re taking away people’s ability to pursue their livelihood or succeed at school.” He wants the Biden administration to revise the proposed telemedicine rules so that providers can waive a patient’s initial in-person evaluation if it will be a barrier to care.

Allowing doctors to virtually diagnose and prescribe treatments has been “life-changing for a lot of people and lifesaving for a few people,” said the University of Nebraska’s Liu.

For the most up-to-date listing, please check with CPSA.

The list of stolen/missing TPPs is updated as we receive the data and includes only the stolen/missing TPPs reported to CPSA. Submit a forgery alert via the ACP website. To report stolen or missing TPPs, physicians and surgeons should contact CPSA. Medication lists are available on the page linked above. Gabapentinoids will be monitored electronically, a TPP form is not required to prescribe them Resources There is emerging evidence of misuse and risk of harm with these medications among certain vulnerable populations, accentuated with concurrent opioid and benzodiazepine use. This includes gabapentin (e.g., Neurontin®) and pregabalin (e.g., Lyrica®). Gabapentinoids (generic and brand name) have also been added as Type 2 products. With this change, a TPP form is no longer required to prescribe generic methylphenidate. An evaluation of this listing status will occur in one year, to assess the benefits or possible challenges associated with re-categorization.Īll stimulants, including methylphenidate products, continue to be monitored electronically as Type 2 TPP medications. This reclassification will allow for a consistent categorization of methylphenidate to simplify prescribing and dispensing, and address some patient issues (such as drug plan coverage policies). This includes dextroamphetamine (e.g., Dexedrine®), lisdexamfetamine (e.g., Vyvanse®) and mixed amphetamine salts (e.g., Adderall®).Īll methylphenidate products, whether generic or brand name, and immediate or delayed release, are now classified as Type 2 medications. On March 3, 2022, the TPP Alberta Steering Committee approved several updates to the TPP Alberta Medication Lists, to allow for additional monitoring and reporting on drugs at risk of misuse or use for non-clinical purposes.Īmphetamine-type stimulants (generic and brand name) have been added to the Type 2 drug list. TPP Alberta medication list (CPSA)Īll stimulants and gabapentinoids are now monitored as Type 2 TPP medications Email: more information, please visit the TPP Alberta resource page found on the CPSA website.

You can get return envelopes for TPP forms from the Alberta College of Pharmacy office: However, pharmacies should keep a copy in case TPP Alberta requests to access to it. Information regarding all other TPP prescriptions is provided to TPP Alberta from dispensing events that are uploaded to Netcare. Please continue to mail the prescriptions listed above to CPSA on a weekly basis.įor the new two-part prescriptions, a copy of the fax or a copy of the secure top copy should be sent. You will need to send a copy of the secure form to TPP Alberta when it is for If the prescription is faxed directly to the pharmacy, the prescriber keeps both original copies.If the prescription is provided directly to the patient, the patient is given the top copy of the TPP secure form to present to a pharmacy. The prescriber keeps the second copy.The Tracked Prescription Program (TPP Alberta) uses a two-part prescription form.

Amphetamine drug list